Reporter Angel Gonzalez poses this question from San Francisco:
What happens when you cram nearly 8,000 biotech executives, investors, venture capitalists and analysts into the narrow, gilded corridors of the Westin hotel on San Francisco’s Union Square? The JP Morgan Healthcare Conference, one of the life sciences sector’s most important pow-wows.
The ambience is that of a beehive. More than 330 companies are presenting, according to JP Morgan officials. Some 2,000 investors and 1,300 venture capitalists are there to meet and greet them.
Several local companies are represented, among them ZymoGenetics, Seattle Genetics and Northstar Neuroscience.
Seattle Genetics CEO Clay Siegall said this was his eighth JP Morgan conference, and he has scheduled 41 meetings with investors and analysts in three days.
“It’s hectic, but I love it,” he said.
Angel will be reporting from the conference this week, on Tech Tracks and in print.